2-54255600-G-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001003937.3(TSPYL6):āc.552C>Gā(p.Asn184Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000174 in 1,613,320 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_001003937.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TSPYL6 | NM_001003937.3 | c.552C>G | p.Asn184Lys | missense_variant | 1/1 | ENST00000317802.9 | NP_001003937.2 | |
ACYP2 | NM_001320586.2 | c.405-49088G>C | intron_variant | ENST00000607452.6 | NP_001307515.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSPYL6 | ENST00000317802.9 | c.552C>G | p.Asn184Lys | missense_variant | 1/1 | 6 | NM_001003937.3 | ENSP00000417919.2 | ||
ACYP2 | ENST00000607452.6 | c.405-49088G>C | intron_variant | 2 | NM_001320586.2 | ENSP00000475986.1 | ||||
ACYP2 | ENST00000394666.8 | c.186-49088G>C | intron_variant | 1 | ENSP00000378161.3 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151912Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000404 AC: 10AN: 247400Hom.: 0 AF XY: 0.0000743 AC XY: 10AN XY: 134562
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1461408Hom.: 0 Cov.: 33 AF XY: 0.0000261 AC XY: 19AN XY: 727016
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151912Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74200
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 23, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at